Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Mitul Gandhi"'
Autor:
Toby A Eyre, Nirav N Shah, Martin Dreyling, Wojciech Jurczak, Yucai Wang, Chan Y Cheah, Yuqin Song, Mitul Gandhi, Christopher Chay, Jeff Sharman, David J Andorsky, Hannah M Messersmith, Amy S Ruppert, Valerie A Muthig, Rodrigo Ito, Michael L Wang
Publikováno v:
Future Oncology. 18:3961-3969
Treatment with covalent Bruton tyrosine kinase inhibitors (BTKi) represents an important advance in the management of relapsed or refractory mantle cell lymphoma, but these treatments are not curative and many patients ultimately relapse. Pirtobrutin
Autor:
Linlin Xu, Mazyar Shadman, Anusha Ponakala, Ian W. Flinn, Moshe Yair Levy, Ryan Porter, John M. Burke, Syed F. Zafar, Jennifer L. Cultrera, Jamal Misleh, Edwin C. Kingsley, Habte Yimer, Benjamin Freeman, Arvind Chaudhry, Praveen K. Tumula, Mitul Gandhi, Aileen Cohen, Dih-Yih Chen, Sudhir Manda, Jeff P. Sharman, Vanitha Ramakrishnan
Publikováno v:
Blood. 140:9269-9271
Autor:
Hun Lee, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Paul Alan Gonzales, Mihir Raval, Rangaswamy Chintapatla, Tatyana Feldman, Habte Yimer, Miguel Islas-Ohlmayer, Asad Dean, Vishal Rana, Mitul Gandhi, John Renshaw, Linda Ho, Michelle A. Fanale, Wenchuan Guo, Christopher A. Yasenchak
Publikováno v:
Blood. 140:763-765
Autor:
Hun Ju Lee, Jeremy S. Abramson, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Domingo Domenech Eva, Brian T. Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Giuseppe Rossi, Uwe H Hahn, Henry Miles Prince, Linda Ho, Wenchuan Guo, Christopher A. Yasenchak, David J. Straus
Publikováno v:
Blood. 140:9399-9401
Autor:
Rodrigo Ito, Toby A. Eyre, Nirav N. Shah, Steven Le Gouill, Martin Dreyling, Elisabeth Vandenberghe, Wojciech Jurczak, Yucai Wang, Chan Y. Cheah, Mitul Gandhi, Christopher Chay, Jeff Sharman, David J. Andorsky, Yuqin Song, Amy Stark, Valerie Muthig, Michael L. Wang
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22
Covalent Bruton's Tyrosine Kinase (BTK) inhibitors (BTKi) have transformed the management of relapsed mantle cell lymphoma (MCL), but many patients will require additional treatment. Pirtobrutinib is a highly selective, non-covalent (reversible) BTKi
Autor:
Tapan M. Kadia, Christopher Benton, Harry P. Erba, Mitul Gandhi, Moshe Y. Levy, Mary-Elizabeth M. Percival, Matthew Ulrickson, Habte Yimer, Min Yu, Zi Chen, Jing Wang, Mingyu Li, Mohammad Ahmad, Dajun Yang, Yifan Zhai
Publikováno v:
Blood. 140:11659-11660
Autor:
Brian T. Hess, Graham P. Collins, Melhem Solh, Mitul Gandhi, Ying Wang, Yajuan Qin, Eric Yu, Pier Luigi Zinzani
Publikováno v:
Blood. 140:12079-12080
Autor:
Rodrigo Ito, Toby A. Eyre, Nirav N. Shah, Steven Le Gouill, Martin Dreyling, Elisabeth Vandenberghe, Wojciech Jurczak, Yucai Wang, Chan Y. Cheah, Mitul Gandhi, Christopher Chay, Jeff Sharman, David J. Andorsky, Yuqin Song, Amy Stark, Valerie Muthig, Michael L. Wang
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S175
Autor:
M. Chung, Carmelo Carlo-Stella, Mitul Gandhi, Yuliya Linhares, Mehdi Hamadani, D. Ungar, H. Adamis
Publikováno v:
Hematological Oncology. 39
Autor:
Keith L Dawson, April Beeks, Sheila Shapouri, Lavanya Sudharshan, Arliene Ravelo, Mitul Gandhi
Publikováno v:
Blood. 136:7-9
Introduction: In 2017, the US FDA granted approval of a subcutaneous (SC) injection form of rituximab as an alternative means of administration for patients with follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), and chronic lymphocytic